‘Whole concept of senior living will change’ if Alzheimer’s drug is approved
By
Lois A. Bowers
Oct 24, 2019
“The whole concept of senior living will change,” CNBC’s Jim Cramer said Tuesday, discussing the news that Biogen and Eisai plan to seek regulatory approval of their investigational treatment for...
Is Alzheimer’s research about to go down a new path?
By
John O'Connor
May 07, 2019
By finding ways to prevent connection losses, the disease progression potentially could be delayed or even reversed, experts said.
Two Alzheimer’s drug trials halted
By
Lois A. Bowers
Mar 22, 2019
Two late-stage clinical trials of a drug for Alzheimer’s disease have been stopped because they aren’t likely to produce promising results, two companies involved with the research announced Thursday.